Skip to content

Tailoring TM-HTN Intervention for Black Patients

Tailoring a Telemedicine Hypertension Management Intervention for Black Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06593119
Acronym
TM-HTN
Enrollment
60
Registered
2024-09-19
Start date
2026-09-01
Completion date
2028-09-01
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Telemedicine, socially disadvantaged, African American or Black patients

Brief summary

Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-care skills, and fails to achieve blood pressure (BP) control.

Detailed description

Telemedicine management of HTN (TM-HTN) can augment and overcome challenges by allowing more support for patients' HTN self-care skills, providing multiple home Blood Pressure values and overcoming failure to appropriately intensify treatment. TM-HTN consists of 1) home BP monitoring, 2) home BP based pharmacotherapy, and 3) telemedicine-based self-management support.

Interventions

TM-HTN intervention includes tailored and frequent self-management support, home blood pressure monitoring, pharmacotherapy, and as-needed assistance for health-related social needs provided by pharmacists, nurses, community health workers, and social workers. This will be compared with usual care

BEHAVIORALUsual Care

This includes usual clinic based HTN care using routinely available clinic resources (e.g., community health worker, social worker). Clinicians can offer self-management support (e.g., dietician referral) or recommend a home BP monitor. These activities mirror current primary care practice.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

60 patients total (30 in the TM-HTN intervention group, 30 in the control group).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must be African American or Black * experiencing socially disadvantage * Patients with systolic Blood Pressure ≥140 mmHg on their last two clinic visits and baseline systolic BP \>130 mmHg using the mean of two research BP values measured by trained staff * Subjects must be on stable Blood Pressure medications for the preceding 6 weeks

Exclusion criteria

* Unable to read or speak English * diminished ability to measure home Blood Pressure * chronic kidney disease ≥stage 4 * persistent/chronic atrial fibrillation * severe hypertension \>180/110 mmHg * acute health changes in past 3 months increasing chance of Blood Pressure instability * terminal illness

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients who are screenedMonth 6Proportion of patients who are screened
Proportion of patients who are eligibleMonth 6Proportion of patients who are eligible
Proportion of patients who agree to participateMonth 6Proportion of patients who agree to participate
Proportion of patients who declineMonth 6Proportion of patients who decline
Number of staff needed and time spent for interventionMonth 6staff training, technical support, troubleshooting
Proportion of completed self-measurement of Blood Pressure at homeMonth 6Proportion of completed self-measurement of BP at home
Proportion of completed self-management contacts.Month 6Proportion of completed self-management contacts.

Secondary

MeasureTime frameDescription
Change in Blood PressureMonth 6Effect size for BP change at 6-months (both arms)
Medication adherenceMonth 6Medication adherence using the Proportion of Days Covered and Domains of Subjective Extent of Nonadherence Measure (both arms)
Feasibility of Intervention Measure [FIM]Month 6measured on a 5-point Likert scale - 'excellent', 'good', 'fair' or 'poor' - higher scores denotes better feasibility
Acceptability of Intervention Measure [AIM]Month 6Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree)
Intervention Appropriateness Measure [IAM]Month 6The IAM uses a 5-point Likert scale, with scores ranging from "Completely Disagree" to "Completely Agree". The mean of the scores is calculated to determine the overall score.
Patient Assessment of Chronic Illness Care [PACIC]Month 6The Patient Assessment of Chronic Illness Care (PACIC) is scored by averaging the responses to all 20 items on the scale. The score ranges from 1 to 5, with higher scores indicating that patients feel more involved in their care and self-management.
Organizational Readiness for Implementing Change [ORIC]Month 6Organizational Readiness for Implementing Change (ORIC) is a 12-item instrument used to determine how well employees at an organization feel they can implement the change in processes required by a proposed intervention. Each item includes a Likert scale from 1 (Disagree) to 5 (Agree) - The range of each scale is -10 through 0 to +10. A negative scale score reflects an overall disagreement with items measuring the stage of change, whereas a positive score represents overall agreement.

Countries

United States

Contacts

CONTACTCamelia Singletary, MPH
Camelia.Singletary@Advocatehealth.org336.713.7210
PRINCIPAL_INVESTIGATORYashashwi Pokharel, MD

Wake Forest University Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026